Skip to content
SearchContact UsDirectionsHome
Whitehead Institute for Biomedical Research
About WhiteheadFaculty and ResearchResearch NewsPublic ProgramsCareer OpportunitiesSupport Whitehead
Research News
Search News Archives

On Topic

Multimedia News Summaries

Paradigm Magazine

Fact Sheets

Video Gallery

Podcast

For the News Media

whitehead home > research news > search news archives > 2004 news stories > interim director of whitehead institute

David Page selected as interim director of Whitehead Institute for Biomedical Research

CAMBRIDGE, Mass. (Dec. 10, 2004) — The Whitehead Institute Board of Directors has announced that David Page will be the interim director of the Institute, effective this month, December 2004.

“David Page is both a great scientist and a wonderful person,” says Alex d’Arbeloff, Chair for Whitehead’s Board of Directors. “We affirm this appointment with the utmost enthusiasm and look forward to working with him.”

Page, a Professor of Biology at Massachusetts Institute of Technology and an Investigator of the Howard Hughes Medical Institute, graduated from Harvard Medical School and the Harvard-MIT Health Sciences and Technology Program in 1984. That same year he came to Whitehead as one of the Institute’s first Fellows.

Throughout his career, Page has focused on the genetic basis of differences between human males and females, and particularly on the roles of the X and Y chromosomes. During the past two decades, Page and his laboratory have revolutionized scientific understanding of the Y chromosome previously thought to be the wasteland of the human genome. For decades, the Y chromosome was thought to be gradually deteriorating due to its inability to fix genetic damage by swapping genetic material with a mate. In the June 2003 issue of Nature, Page and his colleagues (at Whitehead and at Washington University, St. Louis) described a system of self-repair that is unique to the Y chromosome. Page’s lab is now focusing on the question of germ cell sex determination in mammals, and on the development of the embryonic ovary.

“Since the doors of this Institute opened two decades ago, the Whitehead has defined excellence in biology,” says Page. “My goal as Interim Director is to build upon the incredible legacy of three superlative directors: David Baltimore, Gerry Fink, and Sue Lindquist. I’m honored by the Whitehead Institute’s confidence in me.”

Page is the recipient of numerous honors that include the MacArthur Foundation Prize Fellowship (1986), the Amory Prize from the American Academy of Arts and Sciences (1997), and the Curt Stern Award from the American Society of Human Genetics (2003).

 

Whitehead Institute for Biomedical Research is a nonprofit, independent research and educational institution. Wholly independent in its governance, finances and research programs, Whitehead shares a close affiliation with the Massachusetts Institute of Technology through its faculty, who hold joint MIT appointments.


CONTACT

Communications and Public Affairs
Phone: 617-258-5183
Email: newsroom@wi.mit.edu
Whitehead Institute contact information